Frank Takkinen
Stock Analyst at Lake Street
(1.32)
# 3,669
Out of 5,036 analysts
702
Total ratings
38.4%
Success rate
-0.3%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiated Coverage: Buy | $6 → $2.5 | $0.6534 | +282.61% | 18 | Oct 6, 2026 | |
| AXGN Axogen | Reiterated: Buy | $55 | $36.04 | +52.61% | 16 | Oct 5, 2026 | |
| ELUT Elutia | Reiterated: Buy | $5 | $0.8201 | +509.68% | 34 | Oct 5, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $7 | $4.61 | +51.84% | 11 | Oct 1, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $25 | $10.66 | +134.52% | 52 | Sep 30, 2026 | |
| TELA TELA Bio | Reiterated: Buy | $2 | $1.07 | +86.92% | 43 | Sep 30, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2.5 | $0.849 | +194.46% | 21 | Sep 28, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $50 | $15.84 | +215.66% | 6 | Sep 28, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $8 | $4.25 | +88.24% | 23 | Sep 23, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $25 | $18.09 | +38.20% | 15 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.67 | +109.58% | 48 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.514 | +678.21% | 17 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.54 | +293.70% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $13.05 | -8.05% | 14 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $35.05 | -0.14% | 4 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.51 | +99.69% | 19 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $8.47 | +41.68% | 28 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $15 | $11.23 | +33.63% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $1.13 | +165.49% | 39 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $21.61 | +108.24% | 37 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.98 | +168.46% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $85.47 | +40.40% | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.86 | +115.05% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $12.76 | +56.74% | 49 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $14.19 | +69.13% | 5 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $10.51 | +118.84% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.1338 | +2,889.54% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $79.31 | +70.22% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $6.82 | +119.94% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $67.45 | n/a | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $2.55 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.19 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.74 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.80 → $19.95 | $8.16 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.0001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $12 | $0.055 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $2.46 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $10 | $3.73 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.69 | $0.22 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0001 | n/a | 3 | Mar 31, 2022 |
Envoy Medical
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $6 → $2.5
Current: $0.6534
Upside: +282.61%
Axogen
Oct 5, 2026
Reiterated: Buy
Price Target: $55
Current: $36.04
Upside: +52.61%
Elutia
Oct 5, 2026
Reiterated: Buy
Price Target: $5
Current: $0.8201
Upside: +509.68%
MiMedx Group
Oct 1, 2026
Reiterated: Buy
Price Target: $7
Current: $4.61
Upside: +51.84%
ClearPoint Neuro
Sep 30, 2026
Reiterated: Buy
Price Target: $25
Current: $10.66
Upside: +134.52%
TELA Bio
Sep 30, 2026
Reiterated: Buy
Price Target: $2
Current: $1.07
Upside: +86.92%
Hyperfine
Sep 28, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.849
Upside: +194.46%
Tandem Diabetes Care
Sep 28, 2026
Reiterated: Buy
Price Target: $50
Current: $15.84
Upside: +215.66%
TriSalus Life Sciences
Sep 23, 2026
Reiterated: Buy
Price Target: $8
Current: $4.25
Upside: +88.24%
Beta Bionics
Sep 22, 2026
Reiterated: Buy
Price Target: $25
Current: $18.09
Upside: +38.20%
Sep 22, 2026
Reiterated: Hold
Price Target: $3.5
Current: $1.67
Upside: +109.58%
Sep 22, 2026
Reiterated: Buy
Price Target: $4
Current: $0.514
Upside: +678.21%
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.54
Upside: +293.70%
Aug 28, 2026
Reiterated: Buy
Price Target: $8 → $12
Current: $13.05
Upside: -8.05%
Aug 26, 2026
Reiterated: Hold
Price Target: $35
Current: $35.05
Upside: -0.14%
Aug 25, 2026
Reiterated: Buy
Price Target: $13
Current: $6.51
Upside: +99.69%
Aug 19, 2026
Reiterated: Buy
Price Target: $12
Current: $8.47
Upside: +41.68%
Aug 14, 2026
Rated: Buy
Price Target: $21 → $15
Current: $11.23
Upside: +33.63%
Aug 12, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.13
Upside: +165.49%
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $21.61
Upside: +108.24%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $2.98
Upside: +168.46%
Aug 3, 2026
Reiterated: Buy
Price Target: $120
Current: $85.47
Upside: +40.40%
Jul 30, 2026
Reiterated: Buy
Price Target: $4
Current: $1.86
Upside: +115.05%
Jul 29, 2026
Reiterated: Buy
Price Target: $20
Current: $12.76
Upside: +56.74%
Jul 14, 2026
Reiterated: Buy
Price Target: $24
Current: $14.19
Upside: +69.13%
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $10.51
Upside: +118.84%
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.1338
Upside: +2,889.54%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $79.31
Upside: +70.22%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $6.82
Upside: +119.94%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $67.45
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $2.55
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $4.19
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $2.74
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.80 → $19.95
Current: $8.16
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.0001
Upside: n/a
Feb 14, 2023
Reiterated: Buy
Price Target: $4 → $12
Current: $0.055
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $1
Current: $2.46
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $14 → $10
Current: $3.73
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.69
Current: $0.22
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0001
Upside: n/a